Gabapentin and Namzaric drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gabapentin (gabapentin) and Namzaric (donepezil hydrochloride; memantine hydrochloride). Common drug interactions include syncope among females and somnolence among males.
The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Namzaric. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.
What is Namzaric?
Namzaric has active ingredients of donepezil hydrochloride; memantine hydrochloride. eHealthMe is studying from 664 Namzaric users. Check the latest studies of Namzaric.
39 people who take Gabapentin and Namzaric together, and have interactions are studied.

What are the common drug interactions of Gabapentin and Namzaric, by gender? *:
female:
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Vomiting
- Fall
- Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
- Balance disorder
- Carotid artery occlusion (artery blockage)
- Head injury
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
male:
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Fall
- Constipation
- Dementia (madness)
- Dental caries
- Drug ineffective
- Hepatic enzyme increased
- Hypersensitivity
- Infection
- Loss of consciousness
What are the common drug interactions of Gabapentin and Namzaric, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
- Balance disorder
- Carotid artery occlusion (artery blockage)
- Head injury
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
60+:
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Fall
- Constipation
- Dementia (madness)
- Dental caries
- Drug ineffective
- Hepatic enzyme increased
- Hypersensitivity
- Infection
- Loss of consciousness
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 28.21%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 20.51%
- Parkinson's Disease: 6 people, 15.38%
- Neuropathy Peripheral (surface nerve damage): 4 people, 10.26%
- Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 4 people, 10.26%
- High Blood Cholesterol: 4 people, 10.26%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 7.69%
- Hallucinations (sensations that appear real but are created by your mind): 3 people, 7.69%
- Dementia (madness): 3 people, 7.69%
- Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 2 people, 5.13%
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and Namzaric?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gabapentin (322,983 reports)
- Namzaric (664 reports)
Browse all drug interactions of Gabapentin and Namzaric:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gabapentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Namzaric:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gabapentin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Namzaric and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin and donepezil hydrochloride; memantine hydrochloride (the active ingredients of Gabapentin and Namzaric, respectively), and Gabapentin and Namzaric (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Bavencio cause Haematuria Aggravated? - 2 seconds ago
- Could Niacin cause Arthritis? - 10 seconds ago
- Could Amlodipine Besylate cause Rash Pustular? - 22 seconds ago
- Could Nascobal cause Fatigue? - 26 seconds ago
- Could Levoxyl cause Muscle Tightness? - 28 seconds ago
- Could Levothyroxine Sodium cause Coughing Up Blood? - 30 seconds ago
- Drug interactions of Maxzide and Ditropan Xl - 32 seconds ago
- Drug interactions of Activase and Tylenol - 35 seconds ago
- Arthritis and Skin - Clammy - 38 seconds ago
- Sumatriptan Succinate vs. Tramadol Hydrochloride, side effect and effectiveness comparison - 40 seconds ago